Maryam Sharzehee | Molecular Biology | Excellence in Research Award

Published on by Molecular Biologist

Assist. Prof. Dr. Maryam Sharzehee | Molecular Biology | Excellence in Research Award 

Lecturer | Yazd University | Iran

Assist. Prof. Dr. Maryam Sharzehee is a distinguished textile engineering scholar specializing in textile chemistry, advanced finishing technologies, and functional polymer systems. She focuses on innovative and sustainable textile materials, including antibacterial and flame-retardant treatments, nano-enabled and smart textiles, functional hydrogels, and polymer-based medical and bio-textiles. Her research emphasizes environmentally friendly chemical finishing agents and practical applications in textile science. Dr. Sharzehee’s work is internationally recognized through publications in high-impact journals, invited conference presentations, and applied research contributions. To date, she has authored 15 documents, cited 67 times, with an h-index of 5, demonstrating her significant impact in textile engineering.

 

Citation Metrics (Scopus)

80
60
40
20
0

Citations
67

Documents
15

h-index
5

        🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Author Profile
 View Google Scholar Author Profile

Featured Publications

Laura Estrada | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Prof. Laura Estrada | Molecular Biology | Best Researcher Award 

Researcher | Physics department University of Buenos Aires | Argentina

Prof. Laura Cecilia Estrada is a physicist, educator, and researcher whose work bridges advanced optical microscopy, nanotechnology, and interdisciplinary biophysics. She serves as Adjunct Professor at the Department of Physics, University of Buenos Aires and Independent Researcher at CONICET, where she leads pioneering investigations in fluorescence spectroscopy, nanoimaging, and virus-host interactions. Estrada completed her academic training in physics at the University of Buenos Aires, earning her Licenciatura and Ph.D. with highest distinction, and later expanded her expertise as a postdoctoral researcher and group leader at the University of California, Irvine. Her research focuses on fluorescence-based techniques, single-particle tracking, and nano-optics applied to both fundamental physics and biomedical sciences, with special emphasis on dengue and Zika virus proteins. Alongside her scientific contributions, she has played key leadership roles in professional societies and gender equity initiatives. Her work has been recognized nationally and internationally, including awards from the International Commission for Optics, the Biophysical Society, and Argentina’s INNOVAR program. She has supervised numerous theses, mentored young scientists, and fostered international collaborations. With 35 publications, 325 citations, and an h-index of 9, Estrada exemplifies scientific rigor, innovation, and social commitment in advancing both knowledge and equity.

Profile: Scopus

Featured Publications

Sallaberry, I., & Estrada, L. Unraveling viral protein-host membrane interaction for dengue and Zika. Biophysical Journal.

Leon, A., Sallaberry, I., Estrada, L., & Scorticati, C. Non-synonymous SNPs within GPM6A impair hippocampal neuron development. Biochimica et Biophysica Acta, 1872(3). Cited by 2.

Salzman, V., & Estrada, L. Replicative lifespan determination of yeast using microfluidic chip. Biology Open, 13(11). Cited by 5.

Gaggioli, E., Estrada, L., & Bruno, O. Boundary layer structures in transport theory. Physical Review E, 110. Cited by 3.

Philipp, N., Gratton, E., & Estrada, L. Protein-membrane interaction via radial FCS. Methods and Applications in Fluorescence, 11(4). Cited by 12.

Gabriel, M., & Estrada, L. Dengue Virus Capsid Protein Dynamics in live cells. Scientific Reports, 10. Cited by 45.

Maria Camprubi Robles | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Maria Camprubi Robles | Molecular Biology | Best Researcher Award 

Research Scientist | Abbott Laboratories | Spain

Dr. Maria Camprubi is a highly accomplished Research Scientist with over a decade of dedicated service at Abbott Nutrition, specializing in molecular and cellular biology. With strong expertise in nutritional science, she has significantly contributed to the development of innovative products that address sarcopenia, chronic disease, and malnutrition across Europe, the Middle East, and Africa. She holds a Ph.D. in Molecular and Cellular Biology, where she built a strong foundation in cellular processes and metabolic regulation. Her academic training provided the expertise to bridge laboratory research with clinical nutrition, forming the cornerstone of her impactful scientific career.  Dr. Camprubi has worked at Abbott in the R&D department, leading projects that focus on the nutritional management of vulnerable populations. Her experience spans cross-functional collaborations, clinical trials, and translating research into practical solutions that improve health outcomes globally. Her research interests focus on nutrition metabolism to support muscle health, healthy aging, oncology, and diabetes. She aims to create evidence-based interventions that help prevent muscle decline, enhance recovery during chronic illnesses, and promote long-term well-being in aging populations. Dr. Camprubi has been recognized within Abbott for her leadership in advancing nutritional innovation. Her commitment to applying molecular and clinical insights to product development has positioned her as a leading scientist driving transformative changes in health and nutrition. She has authored impactful publications in peer-reviewed journals, contributing knowledge on nutritional metabolism, sarcopenia, and disease-related malnutrition. Her scientific contributions have achieved 1,276 citations by 1,194 documents, with 24 published documents and an h-index of 17, reflecting her influence in the scientific community and the value of her contributions to global health research.

Profile: Scopus

Featured Publications

A prospective, observational study of the effect of a high-calorie, high-protein oral nutritional supplement with HMB in an old and malnourished or at-risk-of-malnutrition population with hip fractures: A FracNut study. Nutrients, 16(8)

The vicious cycle of type 2 diabetes mellitus and skeletal muscle atrophy: Clinical, biochemical, and nutritional bases. Nutrients, 16(1), 172

Heng Zhang | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Heng Zhang | Molecular Biology | Best Researcher Award 

Lecturer | Nankai University | China

Dr. Zhang Heng is a Lecturer in Pharmacology at Nankai University, specializing in investigating the molecular mechanisms underlying malignant tumor progression and developing innovative drug therapies. He earned his B.S., M.S., and Ph.D. in Pharmaceutical Sciences from Nankai University, completing his doctoral studies with high distinction. Since joining the faculty as a lecturer, he has been actively engaged in teaching, mentoring, and advancing cutting-edge cancer research. Dr. Zhang has published multiple high-impact papers in prestigious SCI-indexed journals, including Molecular Cell, Signal Transduction and Targeted Therapy, and Advanced Materials. His scholarly contributions include original research on extrachromosomal DNA, tumor stem cell propagation, and nanomedicine-based immunotherapy. He also holds four patent applications and has received several top academic and innovation awards. Through his research and academic leadership, Dr. Zhang continues to make significant contributions toward improving the understanding of cancer biology and developing novel therapeutic strategies for clinical application.

Professional Profile

ORCID

Education

Dr. Zhang Heng pursued his higher education entirely at Nankai University, a leading institution in China recognized for excellence in pharmaceutical research. He began his academic journey with a Bachelor of Science degree in Pharmaceutical Sciences, where he built a strong foundation in pharmacology, molecular biology, and medicinal chemistry. Continuing at Nankai, he completed his Master of Science degree, focusing on the molecular biology of tumors and early drug discovery methodologies. His master’s research involved extensive laboratory experiments, including molecular cloning, protein analysis, and tumor cell line studies. Dr. Zhang then earned his Ph.D. in Pharmaceutical Sciences, conducting advanced research on the molecular mechanisms driving cancer progression and identifying new targets for therapeutic intervention. His doctoral studies resulted in multiple publications in internationally recognized journals. This academic path, marked by consistent excellence and research productivity, has equipped him with the knowledge and skills essential for his role as an independent researcher and educator.

Experience

Following the completion of his doctoral studies, Dr. Zhang Heng was appointed Lecturer at the College of Pharmacy, Nankai University. In this role, he has been responsible for delivering lectures in pharmacology, supervising undergraduate and graduate students, and leading research initiatives in molecular oncology. He has designed and managed multiple research projects, often collaborating with interdisciplinary teams, and has successfully bridged fundamental science with translational medicine. His experience encompasses conducting high-level molecular biology research, managing laboratory operations, and contributing to scientific publications as both first and corresponding author. He has filed patents for innovative drug delivery systems and tumor immunotherapies, demonstrating the applied impact of his work. Beyond laboratory research, Dr. Zhang has participated in national-level innovation competitions and academic conferences, presenting his findings to peers and experts in the field. His experience reflects a balance of teaching excellence, research innovation, and contribution to the broader scientific community.

Research Interest

Dr. Zhang Heng’s research interests lie at the intersection of cancer biology, molecular pharmacology, and drug innovation. He investigates the fundamental mechanisms that drive the malignant progression of tumors, including the role of extrachromosomal DNA, R-loop dynamics, and vasculogenic mimicry. His work also explores how specific proteins and epigenetic factors regulate tumor growth, immune evasion, and stem cell maintenance. In addition to basic research, Dr. Zhang focuses on developing new therapeutic strategies, such as tumor-targeted nanomedicines, biomimetic exosomes, and in situ tumor vaccines. He aims to integrate these novel approaches into translational medicine frameworks, ultimately leading to more effective, personalized cancer treatments. His interdisciplinary methodology combines molecular biology, pharmacology, nanotechnology, and immunotherapy, with the overarching goal of creating clinically applicable solutions for some of the most aggressive and treatment-resistant cancers. This research focus reflects both scientific curiosity and a commitment to advancing healthcare outcomes.

Award

Dr. Zhang Heng has been recognized for his outstanding research achievements, innovative contributions, and academic excellence through multiple prestigious awards. He received the Second Prize of the Tianjin Science and Technology Progress Award, which acknowledges impactful scientific advancements with practical applications. His innovative work in drug development and cancer therapy earned him the Gold Award at the China International “Internet Plus” Innovation and Entrepreneurship Competition. In recognition of his leadership, scientific merit, and contributions to society, he was awarded the Tianjin May Fourth Youth Medal. While a student, Dr. Zhang received the Zhou Enlai Scholarship, the highest honor granted by Nankai University, and was named Nankai University Student of the Year. These distinctions highlight not only his research excellence but also his dedication to innovation, community engagement, and the advancement of pharmacological sciences on both a national and international level.

Top Noted Publication

Dr. Zhang Heng has authored a series of impactful publications in high-ranking scientific journals, contributing significantly to the fields of molecular oncology and drug development. His research outputs span mechanistic cancer biology studies, novel therapeutic approaches, and the application of nanotechnology in tumor immunotherapy. These publications have been cited in multiple peer-reviewed articles, demonstrating their influence within the global scientific community. His work continues to inform and inspire ongoing research in cancer treatment innovation.

Publications list (single-line prompt):

Title: Extrachromosomal DNA biogenesis is dependent on DNA looping and religation by YY1–Lig3–PARylation complex
Journal: Molecular Cell
Year: 2025

Title: MTA2 triggered R-loop trans-regulates BDH1-mediated β-hydroxybutyrylation and potentiates propagation of hepatocellular carcinoma stem cells
Journal: Signal Transduction and Targeted Therapy
Year: 2021

Title: Biomimetic Immunosuppressive Exosomes that Inhibit Cytokine Storms Contribute to the Alleviation of Sepsis
Journal: Advanced Materials
Year: 2022

Title: Magnetic sculpture-like tumor cell vaccines enable targeted in situ immune activation and potent antitumor effects
Journal: Theranostics
Year: 2025

Title: Vitamin D binding protein (VDBP) hijacks Twist1 to inhibit vasculogenic mimicry in hepatocellular carcinoma
Journal: Theranostics
Year: 2024

Conclusion

Dr. Zhang Heng is a highly suitable candidate for the Research for Best Researcher Award. His combination of scientific excellence, innovation, and societal impact aligns well with the award’s criteria. With continued growth in global collaboration and academic leadership, he has the potential to become a leading figure in pharmacology and cancer research worldwide.

 

Bong-Gyu Mun | Biochemistry | Best Researcher Award

Published on by Molecular Biologist

Prof. Bong-Gyu Mun | Biochemistry | Best Researcher Award

Assistant professor | Chungbuk National University | South Korea

Dr. Bong-Gyu Mun is an accomplished plant biologist and Assistant Professor in the Department of Environmental and Biological Chemistry at Chungbuk National University, South Korea. With a strong background in plant functional genomics and applied life sciences, he has extensively contributed to plant stress physiology, nanoparticle-based plant enhancement, and microbial interactions. Dr. Mun has held several prestigious research roles, including Postdoctoral and Research Professorship positions at Kyungpook National University and the Temasek Life Sciences Laboratory. His research is recognized internationally through numerous publications in top-tier journals, focusing on improving crop resilience through innovative biotechnological and biochemical strategies. Dr. Mun’s work bridges plant molecular biology with sustainable agriculture, aiming to address pressing global food security issues under climate stress. He remains deeply committed to mentoring students, promoting collaborative science, and translating his findings into practical applications in agriculture and crop biotechnology.

Professional Profile

Scopus

ORCID

Education

Dr. Mun’s academic journey showcases a strong progression in the field of plant sciences. He earned his Bachelor’s and Master’s degrees in Applied Life Science from GyeongSang National University in 2010 and 2012, respectively. His master’s research focused on stress signaling pathways in plants. He further deepened his expertise with a Ph.D. in Plant Functional Genomics from Kyungpook National University in August 2017, where he specialized in understanding molecular mechanisms that regulate plant responses to abiotic stresses. His doctoral research laid the foundation for his current investigations into nanoparticle applications and microbial interactions in enhancing plant resilience. Throughout his academic career, Dr. Mun has consistently demonstrated excellence, participating in research programs that emphasize cutting-edge plant biotechnology and environmental stress adaptation.

Experience

Dr. Mun has gained extensive experience in plant molecular biology and biotechnology through a series of progressively advanced academic roles. He began as a Postdoctoral Researcher at the Institute of Agricultural Science and Technology, Kyungpook National University (2017–2018, 2020–2021), and further contributed to the BK21 Plus Project at the same university (2018–2019). He also expanded his global exposure by working at Temasek Life Sciences Laboratory in Singapore (2019–2020), engaging in collaborative research on stress-resistant crops. From 2021 to 2023, he served as a Research Professor at Kyungpook National University. In 2023, Dr. Mun was appointed Assistant Professor at Chungbuk National University, where he now leads research and teaching activities focused on environmental and biological chemistry. His experience spans physiological, biochemical, and genetic approaches in plant science, underscoring his interdisciplinary expertise and leadership in plant stress adaptation.

Research Interest

Dr. Mun’s research interests revolve around plant stress physiology, nanobiotechnology, and plant–microbe interactions. He explores how plants respond to abiotic stressors such as drought, salinity, and heavy metals, focusing on developing stress-resilient crops through biochemical modulators like nitric oxide, melatonin, and chitosan-based nanoparticles. His work investigates the molecular crosstalk between signaling pathways and the synergistic effects of bioformulations like fulvic acid, GSNO, and microbial biostimulants (e.g., PGPR). Recently, he has pioneered research in using nanocarriers for targeted delivery of stress-alleviating compounds, contributing significantly to sustainable agriculture. Dr. Mun is also intrigued by the role of rhizospheric bacteria and how they modulate hormonal and antioxidant responses in plants. Through integrative molecular and physiological approaches, he aims to bridge basic plant science with practical crop management techniques that can help combat the effects of climate change and ensure food security.

Award

Although specific individual awards are not listed in the given data, Dr. Bong-Gyu Mun’s track record of publication in high-impact journals and appointments at leading research institutions is evidence of his recognition in the academic and scientific community. His appointment as an Assistant Professor at Chungbuk National University in 2023 and his previous Research Professorship highlight the trust placed in his academic leadership. His work has also been published multiple times in prestigious international journals such as International Journal of Molecular Sciences, Physiologia Plantarum, Frontiers in Plant Science, and BMC Plant Biology, reflecting both the novelty and impact of his research. These achievements stand as strong indicators of his contributions to advancing plant biotechnology and stress physiology. Dr. Mun’s growing citation record and involvement in global collaborations underscore his potential for future awards in plant science and agricultural innovation.

Top Noted Publications

Dr. Bong-Gyu Mun has authored numerous peer-reviewed publications focused on plant tolerance mechanisms against environmental stress. His recent works include:

1. Enhancing Soybean Salt Tolerance with GSNO and Silicon

  • Authors: Meshari Winledy Msarie, Nusrat Jahan Methela, Mohammad Shafiqul Islam, et al.

  • Journal: International Journal of Molecular Sciences

2. Illite Alleviates Cadmium Stress in Glycine max

  • Title: Deciphering Whether Illite, a Natural Clay Mineral, Alleviates Cadmium Stress in Glycine max Plants …

  • Journal: Sustainability

  • Year: 2024

3. Brown Garlic in Asthma Treatment

  • Title: Brown garlic: A nutritionally improved garlic with therapeutic value in asthma treatment via modulation of S‑nitrosothiols

  • Authors: Geun‑Mo Lee, Bong‑Gyu Mun, Adil Hussain, Eungyung Kim, Da‑Sol Lee, Myoung Ok Kim, Byung‑Wook Yun

  • Journal: Heliyon

  • Year: 2024

4. Melatonin–NO Crosstalk in Plants

  • Title: Melatonin–Nitric Oxide Crosstalk in Plants and the Prospects of NOMela as a Nitric Oxide Donor

  • Authors: Adil Hussain, Brekhna Faheem, Hyung Seok Jang, et al.

  • Journal: International Journal of Molecular Sciences

  • Year: 2024

5. Chitosan‑fulvic Acid Nanoparticles in Maize

  • Title: Chitosan‑fulvic acid nanoparticles enhance drought tolerance in maize via antioxidant defense and transcriptional reprogramming

  • Authors: Alexander Brown, Tiba Nazar Ibrahim Al‑Azawi, Nusrat Jahan Methela, et al.

  • Journal: Physiologia Plantarum

  • Year: 2024

6. Fulvic Acid Nanoparticles for Rice Growth

  • Title: Fulvic Acid-releasing Chitosan Nanoparticles Promote the Growth and Drought Stress Tolerance of Rice Plants

  • Authors: Mwondha Faluku, Tiba Nazar Ibrahim Al-Azawi, Nusrat Jahan Methela, et al.

  • Journal: Journal of Crop Health

  • Year: 2024

7. Pseudomonas koreensis in Arabidopsis

  • Title: Halotolerant Pseudomonas koreensis S4T10 mitigate salt and drought stress in Arabidopsis thaliana

  • Journal: Physiologia Plantarum

  • Year: 2024

8. Bacillus aryabhattai Promotes Soybean Growth

  • Journal: Frontiers in Plant Science

  • Year: 2024

9. Melatonin’s Multifaceted Role in Plants

  • Journal: Frontiers in Plant Science (Review)

  • Year: 2024

10. Chitosan‑GSNO Nanoparticles in Soybean

  • Journal: BMC Plant Biology

  • Year: 2023

Conclusion

Dr. Bong-Gyu Mun stands out as a highly promising candidate for the Best Researcher Award. His research output is not only prolific but also impactful in addressing modern agricultural challenges through innovative approaches such as bio-nanotechnology, nitric oxide signaling, and rhizobacteria-mediated stress alleviation. Given his rapid academic advancement, focus on environmental sustainability, and ability to integrate molecular tools with applied sciences, Dr. Mun is well-deserving of this recognition. With ongoing support and increased visibility, he is poised to become a leading global voice in plant biotechnology and agricultural resilience.

Mina Pencheva | Cell Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Mina Pencheva | Cell Biology | Best Researcher Award 

Doctorate, at Department of Medical Physics and Biophysics, Faculty of Pharmacy, Medical University of Plovdiv, Bulgaria.

Chief Assistant Professor Mina Miroslavova Pencheva, MD, PhD, is a distinguished researcher at the Medical University of Plovdiv, specializing in Medical Physics and Biophysics. With a PhD in Cellular Biology, she explores the intricate effects of radiation, novel organic compounds, and pharmacological agents on human tissues. Dr. Pencheva’s research delves into oncology, radiobiology, and male fertility, emphasizing molecular markers in cancer and the biological impact of synthesized molecules. An active member of various scientific societies, she bridges fundamental research with clinical applications, advancing diagnostics and treatments. Dr. Pencheva has authored numerous impactful publications, contributing significantly to her field.

Profile

Scopus

Google Scholar

ORCID

Education 🎓

Dr. Pencheva holds a PhD in Cellular Biology from the Medical University of Plovdiv (2019), where her dissertation focused on advanced cellular mechanisms. She completed her Master’s degree at Sofia University “St. Kliment Ohridski” in 2002, specializing in Cellular Biology and Pathology. Her robust educational foundation has equipped her with expertise in experimental morphology, pharmacology, and oncology. Throughout her academic journey, Dr. Pencheva has demonstrated a commitment to understanding complex biological systems, paving the way for groundbreaking research in biophysics and molecular medicine.

Experience 🧪

Dr. Pencheva began her academic career as an Assistant at the Department of Anatomy, Histology, and Embryology (2014–2018) before becoming a Chief Assistant Professor in Medical Physics and Biophysics in 2019. She has led and collaborated on numerous research projects, including studies on COVID-19 molecular changes and novel pharmacological compounds. Her role involves both teaching and pioneering research, contributing to advancements in experimental morphology and radiobiology. Her experience spans interdisciplinary collaborations, reflecting her versatile expertise and dedication to scientific discovery and education.

Research Interests 🔬

Dr. Pencheva’s research spans multiple disciplines:

  • Experimental Morphology: Investigates radiation effects on tissues and smooth muscle contractility.
  • Cellular Biology: Focuses on organic molecules’ impact on smooth muscle and immunobiology.
  • Oncology: Studies molecular markers (PD-L1, CD4, CD8, FOXP3, ACE2) in breast cancer, especially triple-negative and HER2-low subtypes.
  • Radiobiology: Explores radiation-induced effects on gastrointestinal serotonin signaling.
  • Pharmacology: Analyzes mebeverine analogs and DIQ derivatives for therapeutic potential.
    Her interdisciplinary approach aims to bridge basic science with clinical applications, enhancing diagnostic and therapeutic strategies.

Awards 🏆

Dr. Pencheva is an esteemed member of:

  • Bulgarian Nuclear Company
  • Union of Scientists in Bulgaria
  • European Society of Pathology
  • International Society of Gynecological Pathology
  • British Academy of Gynecological Pathology
    Her accolades reflect her significant contributions to biomedical research and academic excellence. These memberships highlight her global scientific influence and dedication to advancing pathology, oncology, and biophysics.

Top Noted Publications 📚

  • Black Chokeberry Juice and Aging Testis – Current Issues in Molecular Biology, 2024 Link
  • ACE2 Levels Post-COVID-19 – Biomedicines, 2023 Link
  • Testicular ACE and Sperm Motility – Cells, 2021 Link
  • Serotonin and Radiation Effects – Toxics, 2023 Link
  • Anthranilic Acid Hybrids in Inflammation – Pharmaceuticals, 2023 Link
  • Mebeverine Precursors Activity – Biomedicines, 2023 Link
  • Aronia Juice and Coronary Arteries – Foods, 2022 Link
  • Nitric Oxide Synthesis Stimulation – Applied Sciences, 2022 Link
  • Oyster Mushroom Metabolites – Foods, 2022 Link
  • Phenethylbenzamides for IBS – Molecules, 2024 Link
  • Isoquinoline Derivatives – Molecules, 2024 Link
  • Myenteric Plexus Changes – IJMS, 2024 Link

Conclusion

Dr. Mina Miroslavova Pencheva’s work exemplifies excellence in biomedical research, particularly in the realms of oncology, radiobiology, and pharmacology. Her innovative research on molecular markers in cancer, the biological effects of radiation, and male fertility biomarkers positions her as a leading researcher in her field. Her continued dedication to advancing scientific knowledge, alongside her leadership in critical research projects, makes her a highly deserving candidate for the Best Researcher Award. With further emphasis on clinical translation and public engagement, Dr. Pencheva has the potential to make even more significant contributions to medical science and patient care.